Enrique Murillo, MD

Articles by Enrique Murillo, MD

UFT in Combination as Adjuvant Therapy for Breast Cancer

ByLuis Iglesias, MD,Jose A. Moreno, MD,Enrique Torrija, MD,Enrique Murillo, MD,Manuel Codes, MD,Antonio Duque, MD,Eduardo Garcia, MD,Jose A. Virizuela, MD

September 2nd 1997

Between 1989 and 1993, 409 evaluable patients with breast cancer have been treated with tegafur and uracil (UFT) in an adjuvant setting in two different trials. Data from both trials were reviewed in December 1995 after a

Latest Updated Articles

UFT in Combination as Adjuvant Therapy for Breast Cancer
Published: September 2nd 1997 | Updated:

Enrique Murillo, MD

Articles by Enrique Murillo, MD

UFT in Combination as Adjuvant Therapy for Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC

FDA Grants Regular Approval to Rucaparib in Metastatic CRPC

Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer

Gathering Data to Ascertain Biomarker Specificity in HER2– Breast Cancer

Elacestrant Regimens Yield Meaningful PFS in ER+/HER2– Breast Cancer